Filed under: Ion Channel | Tagged: AstraZeneca, Cellectricon, Ion Channel, Research
AstraZeneca and Cellectricon collaborate on Dynaflow High Throughput Ion Channel Screening
Posted on June 11, 2008 by crimsoncanary
Tags
agonist amitiza Amlodipine Anesiva Angiotensin II AT1 antagonist AstraZeneca ca channel Calcium Channel chloride channel CIC-2 CIC2 cl channel Clevelox Clevidipine Cleviprex CV therapeutics Icagen Ion Channel KCa3.1 K Channel Licensing lidocaine lubiprostone Merck na channel Novartis phase II Potassium Channel preclinical Regulatory Research RU-0211 RU0211 Senicapoc Sodium channel SPI-0211 Sucampo takeda The Medicines Company TRPV1 UCB Vanilloid voltage gated VR1
Leave a Reply
Calendar
Blogroll
Blog at WordPress.com. Theme: Digg 3 Column by WP Designer
